Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiappa, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiappa, K. H.
NEUROLOGY 1980;30:110-123
© 1980 American Academy of Neurology

Pattern shift visual, brainstem auditory, and short-latency somatosensory evoked potentials in multiple sclerosis

Keith H. Chiappa, M.D.

Robert S. Sehwab Computer Facility of the Clinical Neurophysiology Laboratory, Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Boston, MA.

Address correspondence and reprint requests to Dr. Chiappa, Clinical Neurophysiology Laboratory, Department of Neurology, Harvard Medical School, Boston, MA 02114.

Pattern shift visual (PSVER), brainstem auditory (BAER), and short-latency somatosensory (SER) evoked potentials are practical and reliable clinical tests that provide objective measures of impulse conduction in the respective central nervous system (CNS) white matter tracts. In large groups of patients with multiple sclerosis (MS), the abnormality rates were 56, 32, and 60% (PSVER, BAER, and SER, respectively). Evidence of clinically unsuspected lesions was found in 42, 21, and 51%, respectively. Abnormality rates for a definite MS group alone were higher. The tests provide confirmatory and additional evidence for multiple lesions in CNS white matter. They may also provide an objective assessment of the efficacy of therapeutic regimens.

Accepted for publication September 16, 1979.




This article has been cited by other articles:


Home page
Arch NeurolHome page
W. Sencer
Suspicion of Multiple Sclerosis: To Tell or Not to Tell?
Arch Neurol, April 1, 1988; 45(4): 441 - 442.
[Abstract] [PDF]


Home page
Arch NeurolHome page
B. S. Giesser, D. Kurtzberg, H. G. Vaughan Jr, J. C. Arezzo, M. L. Aisen, C. R. Smith, N. G. LaRocca, and L. C. Scheinberg
Trimodal Evoked Potentials Compared With Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis
Arch Neurol, March 1, 1987; 44(3): 281 - 284.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Kimura
Abuse and Misuse of Evoked Potentials as a Diagnostic Test
Arch Neurol, January 1, 1985; 42(1): 78 - 80.
[Abstract] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
N. P. Verma and G. E. Lynn
Auditory Evoked Responses in Multiple Sclerosis: Wave I Abnormality
Arch Otolaryngol Head Neck Surg, January 1, 1985; 111(1): 22 - 24.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. B. Green and M. R. Walcoff
Evoked Potentials in Multiple Sclerosis
Arch Neurol, November 1, 1982; 39(11): 696 - 697.
[Abstract] [PDF]


Home page
Arch NeurolHome page
S. Haldeman, M. Glick, N. N. Bhatia, W. E. Bradley, and B. Johnson
Colonometry, Cystometry, and Evoked Potentials in Multiple Sclerosis
Arch Neurol, November 1, 1982; 39(11): 698 - 701.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.